[Pulmonary opportunistic infections in patients with autoimmune diseases].
Takabayashi
K
K
Koike
T
T
Kurasawa
K
K
Yamazaki
S
S
Sugiyama
T
T
Matsumura
R
R
Yoshida
H
H
Tomioka
H
H
Yoshida
S
S
Ohshima
H
H
D000328:Adult; D000368:Aged; D001327:Autoimmune Diseases / Q000150:complications*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000008:administration & dosage; D008172:Lung Diseases, Fungal / Q000150:complications* / Q000517:prevention & control; D008297:Male; D008875:Middle Aged; D009181:Mycoses / Q000150:complications* / Q000517:prevention & control; D009894:Opportunistic Infections / Q000150:complications* / Q000517:prevention & control; D011020:Pneumonia, Pneumocystis / Q000150:complications* / Q000517:prevention & control; D011239:Prednisolone / Q000008:administration & dosage / Q000009:adverse effects; D013420:Sulfamethoxazole / Q000008:administration & dosage; D014295:Trimethoprim / Q000008:administration & dosage; D014397:Tuberculosis, Pulmonary / Q000150:complications* / Q000517:prevention & control
D011239:Prednisolone; D014295:Trimethoprim; D013420:Sulfamethoxazole; D007538:Isoniazid